Hikma Pharmaceuticals Plc Director/PDMR Shareholding

Data : 27/02/2020 @ 17:40
Fonte : UK Regulatory (RNS & others)
Titolo : Hikma Pharmaceuticals Plc (HIK)
Quotazione : 2562.0  47.0 (1.87%) @ 17:35
Quotazione Hikma Pharmaceuticals Grafico

Hikma Pharmaceuticals Plc Director/PDMR Shareholding

Grafico Azioni Hikma Pharmaceuticals (LSE:HIK)
Storico


Da Feb 2020 a Mag 2020

Clicca qui per i Grafici di Hikma Pharmaceuticals

TIDMHIK

RNS Number : 4008E

Hikma Pharmaceuticals Plc

27 February 2020

Hikma Pharmaceuticals PLC - EIP Awards

LONDON, 27 February 2020: Hikma Pharmaceuticals PLC (LSE: HIK) (NasdaqDubai: HIK)

(LEI: 549300BNS685UXH4JI75) announces that the Remuneration Committee made the following conditional awards under the Hikma Pharmaceuticals PLC 2014 Executive Incentive Plan (the "EIP") to Persons Discharging Managerial Responsibility ("PDMR") of the Company.

Awards under the EIP were made on 27 February 2020 at a price of 1,930 pence per Ordinary Share (being the average price for the 30-day period prior to 31 December 2019, in accordance with the EIP rules) as follows:

Notification and public disclosure of transactions by persons discharging managerial responsibilities

Said Darwazah

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Said Darwazah 
 2    Reason for the notification 
 a)   Position/status           Executive Chairman 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             (Shares) 
       instrument, type          ID Code: GB00B0LCW083 
       of instrument 
       and identification 
       code 
 b)   Nature of the             The Company granted the named individual above 
       transaction               a conditional award to acquire Shares under 
                                 Element B of the 2014 Executive Incentive Plan 
                                 (EIP). Shares under Element B EIP award will 
                                 vest after 2 years. 
 c)   Price(s) and              Price(s): GBP19.30 
       volume(s)                 Volume(s): 47,169 
 d)   Aggregated information    N/A 
 e)   Date of the transaction   27 February 2020 
 f)   Place of the              London Stock Exchange (XLON) 
       transaction 
 

Said Darwazah

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Said Darwazah 
 2    Reason for the notification 
 a)   Position/status           Executive Chairman 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             (Shares) 
       instrument, type          ID Code: GB00B0LCW083 
       of instrument 
       and identification 
       code 
 b)   Nature of the             The Company granted the named individual above 
       transaction               a conditional award to acquire Shares under 
                                 Element C of the 2014 Executive Incentive Plan 
                                 (EIP). Shares under Element C EIP award will 
                                 vest after 3 years. 
 c)   Price(s) and              Price(s): GBP19.30 
       volume(s)                 Volume(s): 27,057 
 d)   Aggregated information    N/A 
 e)   Date of the transaction   27 February 2020 
 f)   Place of the              London Stock Exchange (XLON) 
       transaction 
 

Sigurdur Olafsson

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Sigurdur Olafsson 
 2    Reason for the notification 
 a)   Position/status           Chief Executive Officer 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             (Shares) 
       instrument, type          ID Code: GB00B0LCW083 
       of instrument 
       and identification 
       code 
 b)   Nature of the             The Company granted the named individual above 
       transaction               a conditional award to acquire Shares under 
                                 Element B of the 2014 Executive Incentive Plan 
                                 (EIP). Shares under Element B EIP award will 
                                 vest after 2 years. 
 c)   Price(s) and              Price(s): GBP19.30 
       volume(s)                 Volume(s): 53,148 
 d)   Aggregated information    N/A 
 e)   Date of the transaction   27 February 2020 
 f)   Place of the              London Stock Exchange (XLON) 
       transaction 
 

Sigurdur Olafsson

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Sigurdur Olafsson 
 2    Reason for the notification 
 a)   Position/status           Chief Executive Officer 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             (Shares) 
       instrument, type          ID Code: GB00B0LCW083 
       of instrument 
       and identification 
       code 
 b)   Nature of the             The Company granted the named individual above 
       transaction               a conditional award to acquire Shares under 
                                 Element C of the 2014 Executive Incentive Plan 
                                 (EIP). Shares under Element C EIP award will 
                                 vest after 3 years. 
 c)   Price(s) and              Price(s): GBP19.30 
       volume(s)                 Volume(s): 31,426 
 d)   Aggregated information    N/A 
 e)   Date of the transaction   27 February 2020 
 f)   Place of the              London Stock Exchange (XLON) 
       transaction 
 

Mazen Darwazah

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Mazen Darwazah 
 2    Reason for the notification 
 a)   Position/status           Executive Vice Chairman 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             (Shares) 
       instrument, type          ID Code: GB00B0LCW083 
       of instrument 
       and identification 
       code 
 b)   Nature of the             The Company granted the named individual above 
       transaction               a conditional award to acquire Shares under 
                                 Element B of the 2014 Executive Incentive Plan 
                                 (EIP). Shares under Element B EIP award will 
                                 vest after 2 years. 
 c)   Price(s) and              Price(s): GBP19.30 
       volume(s)                 Volume(s): 32,993 
 d)   Aggregated information    N/A 
 e)   Date of the transaction   27 February 2020 
 f)   Place of the              London Stock Exchange (XLON) 
       transaction 
 

Mazen Darwazah

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Mazen Darwazah 
 2    Reason for the notification 
 a)   Position/status           Executive Vice Chairman 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             (Shares) 
       instrument, type          ID Code: GB00B0LCW083 
       of instrument 
       and identification 
       code 
 b)   Nature of the             The Company granted the named individual above 
       transaction               a conditional award to acquire Shares under 
                                 Element C of the 2014 Executive Incentive Plan 
                                 (EIP). Shares under Element C EIP award will 
                                 vest after 3 years. 
 c)   Price(s) and              Price(s): GBP19.30 
       volume(s)                 Volume(s): 18,831 
 d)   Aggregated information    N/A 
 e)   Date of the transaction   27 February 2020 
 f)   Place of the              London Stock Exchange (XLON) 
       transaction 
 

Bassam Kanaan

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Bassam Kanaan 
 2    Reason for the notification 
 a)   Position/status           EVP, Corporate Development and M&A 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             (Shares) 
       instrument, type          ID Code: GB00B0LCW083 
       of instrument 
       and identification 
       code 
 b)   Nature of the             The Company granted the named individual above 
       transaction               a conditional award to acquire Shares under 
                                 Element B of the 2014 Executive Incentive Plan 
                                 (EIP). Shares under Element B EIP award will 
                                 vest after 2 years. 
 c)   Price(s) and              Price(s): GBP19.30 
       volume(s)                 Volume(s): 22,610 
 d)   Aggregated information    N/A 
 e)   Date of the transaction   27 February 2020 
 f)   Place of the              London Stock Exchange (XLON) 
       transaction 
 

Bassam Kanaan

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Bassam Kanaan 
 2    Reason for the notification 
 a)   Position/status           EVP, Corporate Development and M&A 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             (Shares) 
       instrument, type          ID Code: GB00B0LCW083 
       of instrument 
       and identification 
       code 
 b)   Nature of the             The Company granted the named individual above 
       transaction               a conditional award to acquire Shares under 
                                 Element C of the 2014 Executive Incentive Plan 
                                 (EIP). Shares under Element C EIP award will 
                                 vest after 3 years. 
 c)   Price(s) and              Price(s): GBP19.30 
       volume(s)                 Volume(s): 17,007 
 d)   Aggregated information    N/A 
 e)   Date of the transaction   27 February 2020 
 f)   Place of the              London Stock Exchange (XLON) 
       transaction 
 

Khalid Nabilsi

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Khalid Nabilsi 
 2    Reason for the notification 
 a)   Position/status           Chief Financial Officer 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             (Shares) 
       instrument, type          ID Code: GB00B0LCW083 
       of instrument 
       and identification 
       code 
 b)   Nature of the             The Company granted the named individual above 
       transaction               a conditional award to acquire Shares under 
                                 Element B of the 2014 Executive Incentive Plan 
                                 (EIP). Shares under Element B EIP award will 
                                 vest after 2 years. 
 c)   Price(s) and              Price(s): GBP19.30 
       volume(s)                 Volume(s): 22,709 
 d)   Aggregated information    N/A 
 e)   Date of the transaction   27 February 2020 
 f)   Place of the              London Stock Exchange (XLON) 
       transaction 
 

Khalid Nabilsi

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Khalid Nabilsi 
 2    Reason for the notification 
 a)   Position/status           Chief Financial Officer 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             (Shares) 
       instrument, type          ID Code: GB00B0LCW083 
       of instrument 
       and identification 
       code 
 b)   Nature of the             The Company granted the named individual above 
       transaction               a conditional award to acquire Shares under 
                                 Element C of the 2014 Executive Incentive Plan 
                                 (EIP). Shares under Element C EIP award will 
                                 vest after 3 years. 
 c)   Price(s) and              Price(s): GBP19.30 
       volume(s)                 Volume(s): 17,180 
 d)   Aggregated information    N/A 
 e)   Date of the transaction   27 February 2020 
 f)   Place of the              London Stock Exchange (XLON) 
       transaction 
 

Riad Mishlawi

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Riad Mishlawi 
 2    Reason for the notification 
 a)   Position/status           President, Injectables 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             (Shares) 
       instrument, type          ID Code: GB00B0LCW083 
       of instrument 
       and identification 
       code 
 b)   Nature of the             The Company granted the named individual above 
       transaction               a conditional award to acquire Shares under 
                                 Element B of the 2014 Executive Incentive Plan 
                                 (EIP). Shares under Element B EIP award will 
                                 vest after 2 years. 
 c)   Price(s) and              Price(s): GBP19.30 
       volume(s)                 Volume(s): 27,086 
 d)   Aggregated information    N/A 
 e)   Date of the transaction   27 February 2020 
 f)   Place of the              London Stock Exchange (XLON) 
       transaction 
 

Riad Mishlawi

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Riad Mishlawi 
 2    Reason for the notification 
 a)   Position/status           President, Injectables 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             (Shares) 
       instrument, type          ID Code: GB00B0LCW083 
       of instrument 
       and identification 
       code 
 b)   Nature of the             The Company granted the named individual above 
       transaction               a conditional award to acquire Shares under 
                                 Element C of the 2014 Executive Incentive Plan 
                                 (EIP). Shares under Element C EIP award will 
                                 vest after 3 years. 
 c)   Price(s) and              Price(s): GBP19.30 
       volume(s)                 Volume(s): 22,437 
 d)   Aggregated information    N/A 
 e)   Date of the transaction   27 February 2020 
 f)   Place of the              London Stock Exchange (XLON) 
       transaction 
 

Majda Labadi

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Majda Labadi 
 2    Reason for the notification 
 a)   Position/status           EVP, Organisational Development 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             (Shares) 
       instrument, type          ID Code: GB00B0LCW083 
       of instrument 
       and identification 
       code 
 b)   Nature of the             The Company granted the named individual above 
       transaction               a conditional award to acquire Shares under 
                                 Element B of the 2014 Executive Incentive Plan 
                                 (EIP). Shares under Element B EIP award will 
                                 vest after 2 years. 
 c)   Price(s) and              Price(s): GBP19.30 
       volume(s)                 Volume(s): 14,211 
 d)   Aggregated information    N/A 
 e)   Date of the transaction   27 February 2020 
 f)   Place of the              London Stock Exchange (XLON) 
       transaction 
 

Majda Labadi

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Majda Labadi 
 2    Reason for the notification 
 a)   Position/status           EVP, Organisational Development 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             (Shares) 
       instrument, type          ID Code: GB00B0LCW083 
       of instrument 
       and identification 
       code 
 b)   Nature of the             The Company granted the named individual above 
       transaction               a conditional award to acquire Shares under 
                                 Element C of the 2014 Executive Incentive Plan 
                                 (EIP). Shares under Element C EIP award will 
                                 vest after 3 years. 
 c)   Price(s) and              Price(s): GBP19.30 
       volume(s)                 Volume(s): 10,690 
 d)   Aggregated information    N/A 
 e)   Date of the transaction   27 February 2020 
 f)   Place of the              London Stock Exchange (XLON) 
       transaction 
 

Susan Ringdal

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Susan Ringdal 
 2    Reason for the notification 
 a)   Position/status           EVP, Strategic Planning and Global Affairs 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             (Shares) 
       instrument, type          ID Code: GB00B0LCW083 
       of instrument 
       and identification 
       code 
 b)   Nature of the             The Company granted the named individual above 
       transaction               a conditional award to acquire Shares under 
                                 Element B of the 2014 Executive Incentive Plan 
                                 (EIP). Shares under Element B EIP award will 
                                 vest after 2 years. 
 c)   Price(s) and              Price(s): GBP19.30 
       volume(s)                 Volume(s): 11,749 
 d)   Aggregated information    N/A 
 e)   Date of the transaction   27 February 2020 
 f)   Place of the              London Stock Exchange (XLON) 
       transaction 
 

Susan Ringdal

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Susan Ringdal 
 2    Reason for the notification 
 a)   Position/status           EVP, Strategic Planning and Global Affairs 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             (Shares) 
       instrument, type          ID Code: GB00B0LCW083 
       of instrument 
       and identification 
       code 
 b)   Nature of the             The Company granted the named individual above 
       transaction               a conditional award to acquire Shares under 
                                 Element C of the 2014 Executive Incentive Plan 
                                 (EIP). Shares under Element C EIP award will 
                                 vest after 3 years. 
 c)   Price(s) and              Price(s): GBP19.30 
       volume(s)                 Volume(s): 8,874 
 d)   Aggregated information    N/A 
 e)   Date of the transaction   27 February 2020 
 f)   Place of the              London Stock Exchange (XLON) 
       transaction 
 

Brian Hoffmann

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Brian Hoffmann 
 2    Reason for the notification 
 a)   Position/status           President, US Generics 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             (Shares) 
       instrument, type          ID Code: GB00B0LCW083 
       of instrument 
       and identification 
       code 
 b)   Nature of the             The Company granted the named individual above 
       transaction               a conditional award to acquire Shares under 
                                 Element B of the 2014 Executive Incentive Plan 
                                 (EIP). Shares under Element B EIP award will 
                                 vest after 2 years. 
 c)   Price(s) and              Price(s): GBP19.30 
       volume(s)                 Volume(s): 14,441 
 d)   Aggregated information    N/A 
 e)   Date of the transaction   27 February 2020 
 f)   Place of the              London Stock Exchange (XLON) 
       transaction 
 

Brian Hoffmann

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Brian Hoffmann 
 2    Reason for the notification 
 a)   Position/status           President, US Generics 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             (Shares) 
       instrument, type          ID Code: GB00B0LCW083 
       of instrument 
       and identification 
       code 
 b)   Nature of the             The Company granted the named individual above 
       transaction               a conditional award to acquire Shares under 
                                 Element C of the 2014 Executive Incentive Plan 
                                 (EIP). Shares under Element C EIP award will 
                                 vest after 3 years. 
 c)   Price(s) and              Price(s): GBP19.30 
       volume(s)                 Volume(s): 11,962 
 d)   Aggregated information    N/A 
 e)   Date of the transaction   27 February 2020 
 f)   Place of the              London Stock Exchange (XLON) 
       transaction 
 

Henriette Nielsen

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Henriette Nielsen 
 2    Reason for the notification 
 a)   Position/status           EVP, Business Operations 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             (Shares) 
       instrument, type          ID Code: GB00B0LCW083 
       of instrument 
       and identification 
       code 
 b)   Nature of the             The Company granted the named individual above 
       transaction               a conditional award to acquire Shares under 
                                 Element B of the 2014 Executive Incentive Plan 
                                 (EIP). Shares under Element B EIP award will 
                                 vest after 2 years. 
 c)   Price(s) and              Price(s): GBP19.30 
       volume(s)                 Volume(s): 15,635 
 d)   Aggregated information    N/A 
 e)   Date of the transaction   27 February 2020 
 f)   Place of the              London Stock Exchange (XLON) 
       transaction 
 

Henriette Nielsen

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Henriette Nielsen 
 2    Reason for the notification 
 a)   Position/status           EVP, Business Operations 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             (Shares) 
       instrument, type          ID Code: GB00B0LCW083 
       of instrument 
       and identification 
       code 
 b)   Nature of the             The Company granted the named individual above 
       transaction               a conditional award to acquire Shares under 
                                 Element C of the 2014 Executive Incentive Plan 
                                 (EIP). Shares under Element C EIP award will 
                                 vest after 3 years. 
 c)   Price(s) and              Price(s): GBP19.30 
       volume(s)                 Volume(s): 13,060 
 d)   Aggregated information    N/A 
 e)   Date of the transaction   27 February 2020 
 f)   Place of the              London Stock Exchange (XLON) 
       transaction 
 

Shahin Fesharaki

 
1   Details of the person discharging managerial responsibilities 
     / person closely associated 
a)  Name                     Shahin Fesharaki 
2   Reason for the notification 
a)  Position/status          Chief Scientific Officer 
b)  Initial notification     Initial notification 
     /Amendment 
3   Details of the issuer, emission allowance market participant, 
     auction platform, auctioneer or auction monitor 
a)  Name                     Hikma Pharmaceuticals PLC 
b)  LEI                      549300BNS685UXH4JI75 
4   Details of the transaction(s): section to be repeated for 
     (i) each type of instrument; (ii) each type of transaction; 
     (iii) each date; and (iv) each place where transactions have 
     been conducted 
a)  Description of           Description: Ordinary shares of 10 pence each 
     the financial            (Shares) 
     instrument, type         ID Code: GB00B0LCW083 
     of instrument 
     and identification 
     code 
b)  Nature of the            The Company granted the named individual above 
     transaction              a conditional award to acquire Shares under 
                              Element B of the 2014 Executive Incentive Plan 
                              (EIP). Shares under Element B EIP award will 
                              vest after 2 years. 
c)  Price(s) and             Price(s): GBP19.30 
     volume(s)                Volume(s): 7,752 
d)  Aggregated information   N/A 
e)  Date of the transaction  27 February 2020 
f)  Place of the             London Stock Exchange (XLON) 
     transaction 
 

Shahin Fesharaki

 
1   Details of the person discharging managerial responsibilities 
     / person closely associated 
a)  Name                     Shahin Fesharaki 
2   Reason for the notification 
a)  Position/status          Chief Scientific Officer 
b)  Initial notification     Initial notification 
     /Amendment 
3   Details of the issuer, emission allowance market participant, 
     auction platform, auctioneer or auction monitor 
a)  Name                     Hikma Pharmaceuticals PLC 
b)  LEI                      549300BNS685UXH4JI75 
4   Details of the transaction(s): section to be repeated for 
     (i) each type of instrument; (ii) each type of transaction; 
     (iii) each date; and (iv) each place where transactions have 
     been conducted 
a)  Description of           Description: Ordinary shares of 10 pence each 
     the financial            (Shares) 
     instrument, type         ID Code: GB00B0LCW083 
     of instrument 
     and identification 
     code 
b)  Nature of the            The Company granted the named individual above 
     transaction              a conditional award to acquire Shares under 
                              Element C of the 2014 Executive Incentive Plan 
                              (EIP). Shares under Element C EIP award will 
                              vest after 3 years. 
c)  Price(s) and             Price(s): GBP19.30 
     volume(s)                Volume(s): 5,831 
d)  Aggregated information   N/A 
e)  Date of the transaction  27 February 2020 
f)  Place of the             London Stock Exchange (XLON) 
     transaction 
 

Peter Speirs

Company Secretary, responsible for releasing this announcement

+44 (0) 20 7399 2760

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHBLGDDSGDDGGR

(END) Dow Jones Newswires

February 27, 2020 11:40 ET (16:40 GMT)

La tua Cronologia
BIT
BMPS
Monte Pasc..
BITI
FTSEMIB
FTSE Mib
BIT
UCG
Unicredit
NASDAQ
AAPL
Apple
FX
EURUSD
Euro vs Do..
Le azioni che visualizzerai appariranno in questo riquadro, così potrai facilmente tornare alle quotazioni di tuo interesse.

Registrati ora per creare la tua watchlist personalizzata in tempo reale streaming.

Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

P: V:it D:20200526 00:58:22